Contraceptive compact gel

Abstract

The invention relates to the technical field of medicines, and provides contraceptive compact gel. The contraceptive compact gel comprises the following material components in percentage by weight of3%-5% of an aloe extract, 3%-5% of a common cnidium fruit extract, 3%-6% of a portulaca oleracea extract, 2%-5% of glucan, 0.3%-0.5% of hydroxyacetophenone, 1%-3% of palmitoyl pentapeptide-4, 5% of aradix sophorae flavescentis extract, 3% of 50ppm silver ions, 0.1%-0.3% of nonoxinol, 8.05%-13.1% of a hydrating agent, 1%-2% of cellulose, 0.1%-1% of a depressant, 0.05%-0.2% of a PH adjusting agentand 50.9%-70.4% of deionized water. Through the adoption of the contraceptive compact gel, the problems that existing contraceptive medicines are poor in use effects and enable bodies to have adversereactions are solved.

Description

technical field [0001] The invention relates to the technical field of medicines, in particular to a contraceptive firming gel. Background technique [0002] At present, oral contraceptives and external contraceptives are the main contraceptive methods today. Among them, oral contraceptives have high-efficiency and good contraceptive effects, and are used by many people, but the side effects of oral contraceptives are also very obvious, and there are many contraindications. The most widely used external contraceptives at home and abroad are mainly nonoxynol-9, alkanol ether, menthol ether, etc. Their contraceptive effects have been fully affirmed clinically, and they have played a major role in the world's family planning. role. However, it has been reported that if such drugs are used extensively, for a long time and in large quantities, at the usual concentration of vaginal contraceptive preparations, such drugs may cause damage and rupture of the vaginal and cervical ep...

AI Technical Summary

Problems solved by technology

However, it has been reported that if such drugs are used extensively, for a long time and in large quantities, at the usual concentration of vaginal contraceptive preparations, such drugs may cause damage and rupture of the vaginal and cervical epithelial mucosa, and cause pathogens such as Candida albicans and Staphylococcus aureus. Microbial invasion creates opportunities, so not only does it not have the function of contraception, but it is more likely to cause reproductive tract infection and inflammation; at the same time, this type of drug will also destroy the living environment of normal vaginal flora and affect the balance of the body, resulting in low body resistance and inflammation. The loss outweighs the gain